Other / n/a


Noel G McElvaney
Peter Branagan
Catherine M Greene



drug design humans anti inflammatory agents toll like receptors cystic fibrosis gene expression regulation non steroidal medicine and health sciences anti inflammatory agents non steroidal

Toll-like receptors as therapeutic targets in cystic fibrosis. (2008)

Abstract Background: Toll-like receptors (TLRs) are pattern recognition receptors that act as a first-line of defence in the innate immune response by recognising and responding to conserved molecular patterns in microbial factors and endogenous danger signals. Cystic fibrosis (CF)-affected airways represent a milieu potentially rich in TLR agonists and the chronic inflammatory phenotype evident in CF airway epithelial cells is probably due in large part to activation of TLRs. Objective/methods: To examine the prospects of developing novel therapies for CF by targeting TLRs. We outline the expression and function of TLRs and explore the therapeutic potential of naturally-occurring and synthetic TLR inhibitors for CF. Results/conclusion: Modulation of TLRs has therapeutic potential for the inflammatory lung manifestations of CF.
Collections Ireland -> Royal College of Surgeons in Ireland -> Medicine Articles
Ireland -> Royal College of Surgeons in Ireland -> Department of Medicine

Full list of authors on original publication

Noel G McElvaney, Peter Branagan, Catherine M Greene

Experts in our system

Noel G McElvaney
Royal College of Surgeons in Ireland
Total Publications: 194
Catherine M Greene
Royal College of Surgeons in Ireland
Total Publications: 150